Glimepiride IP 2 mg Pioglitazone 15 mg Metformin Hydrochloride IP 500 mg (In Extended Release Form) TAB

Name: Glimepiride IP 2 mg Pioglitazone 15 mg Metformin Hydrochloride IP 500 mg (In Extended Release Form) TAB
Brand: CARE FORMULATION LABS PRIVATE LIMITED
Price: 72.87 INR
Availability: InStock

Price 72.87 INR/ Pack

Get a Price/Quote

MOQ : 100 Packs

Glimepiride IP 2 mg Pioglitazone 15 mg Metformin Hydrochloride IP 500 mg (In Extended Release Form) TAB Specification

Molecular Formula
C20H30Cl2O15

Appearance
Light blue capsules with white body.

Type
Tablet

Feature
10x tablet pack

Glimepiride IP 2 mg Pioglitazone 15 mg Metformin Hydrochloride IP 500 mg (In Extended Release Form) TAB Trade Information

Minimum Order Quantity
100 Packs

Supply Ability
5000 Packs Per Month

Delivery Time
7 Days

About Glimepiride IP 2 mg Pioglitazone 15 mg Metformin Hydrochloride IP 500 mg (In Extended Release Form) TAB

Description

Each uncoated bilayered tablet contains : Glimepiride IP 2 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500 mg (In Extended Release Form)

Doses

As Directed by Physician

Indication

Glimepiride is an oral diabetes medicine that helps control blood sugar levels.
Glimepiride is used together with diet and exercise to treat type 2 diabetes. Insulin or other diabetes medicines are sometimes used in combination with glimepiride if needed.

Advanced Diabetes Management

This triple-combination tablet offers an effective solution for type 2 diabetes by integrating Glimepiride, Pioglitazone, and Metformin in a single, extended-release dosage. It provides comprehensive blood sugar control, reducing pill burden and improving patient compliance.

Quality Assured and Widely Available

Manufactured to stringent quality standards, these tablets are distributed by multiple stakeholders including exporters, wholesalers, and retailers throughout India. The packaging of 10 tablets ensures convenience and ease of distribution for healthcare providers and patients alike.

FAQ's of Glimepiride IP 2 mg Pioglitazone 15 mg Metformin Hydrochloride IP 500 mg (In Extended Release Form) TAB:

Q: How should Glimepiride IP 2 mg Pioglitazone 15 mg Metformin Hydrochloride IP 500 mg tablets be taken?

A: These tablets are generally taken once daily with meals to reduce gastrointestinal side effects. It is important to follow the dosage and instructions provided by your healthcare provider to ensure safety and efficacy.

Q: What is the benefit of the extended-release formulation in this medication?

A: The extended-release form helps maintain steady blood sugar levels throughout the day, providing longer-lasting effects and minimizing peaks and troughs in glucose control.

Q: When can I expect to see improvements in my blood sugar levels after starting this tablet?

A: Many patients begin to notice improvements in their blood sugar readings within a few days to weeks, though optimal results might require consistent use and monitoring over several weeks.

Q: Where is this combination tablet available for purchase?

A: This medication is widely available through dealers, distributors, retailers, and wholesalers across India. You may obtain it at major pharmacies or through authorized suppliers.

Q: What is the process for obtaining this medication as a healthcare provider or distributor?

A: Healthcare providers and distributors can source these tablets directly from licensed manufacturers, wholesalers, or authorized dealers operating in the Indian pharmaceutical market.

Q: How is the appearance of the tablet distinguished?

A: The tablet can be identified by its light blue, capsule shape with a white body, allowing for easy recognition and reducing medication errors.

Q: Who should not use this combination medication?

A: This medication is not intended for individuals with type 1 diabetes, severe liver or kidney impairment, or a history of hypersensitivity to any of its ingredients. Always consult your healthcare provider before beginning this therapy.

Tell us about your requirement